ZCCHC17 has recently been proposed as a master regulator in Alzheimer’s disease and is expressed in neuronal cells where levels are seen to drastically decrease early in AD, before significant neuronal cell loss or gliosis. This evidence concerns the gene ZCCHC17 and early-onset autosomal dominant Alzheimer disease.